User profiles for Lawrence Schwartz

Lawrence B Schwartz

Virginia Commonwealth University OR Washington University OR Harvard Medical School
Verified email at vcu.edu
Cited by 47073

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

…, P Therasse, J Bogaerts, LH Schwartz… - European journal of …, 2009 - Elsevier
BACKGROUND: Assessment of the change in tumour burden is an important feature of the
clinical evaluation of cancer therapeutics: both tumour shrinkage (objective response) and …

[HTML][HTML] Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification

…, SF Barrington, F Cavalli, LH Schwartz… - Journal of clinical …, 2014 - ncbi.nlm.nih.gov
The purpose of this work was to modernize recommendations for evaluation, staging, and
response assessment of patients with Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (…

The multimodal brain tumor image segmentation benchmark (BRATS)

…, M Ryan, D Sarikaya, L Schwartz… - IEEE transactions on …, 2014 - ieeexplore.ieee.org
In this paper we report the set-up and results of the Multimodal Brain Tumor Image
Segmentation Benchmark (BRATS) organized in conjunction with the MICCAI 2012 and 2013 …

Artificial intelligence in radiology

…, C Parmar, J Quackenbush, LH Schwartz… - Nature Reviews …, 2018 - nature.com
Artificial intelligence (AI) algorithms, particularly deep learning, have demonstrated
remarkable progress in image-recognition tasks. Methods ranging from convolutional neural …

The lung image database consortium (LIDC) and image database resource initiative (IDRI): a completed reference database of lung nodules on CT scans

…, I Petkovska, LE Quint, LH Schwartz… - Medical …, 2011 - Wiley Online Library
Purpose: The development of computer‐aided diagnostic (CAD) methods for lung nodule
detection, classification, and quantitative assessment can be facilitated through a well‐…

iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics

…, J Bogaerts, A Perrone, R Ford, LH Schwartz… - The Lancet …, 2017 - thelancet.com
Tumours respond differently to immunotherapies compared with chemotherapeutic drugs,
raising questions about the assessment of changes in tumour burden—a mainstay of …

Artificial intelligence in cancer imaging: clinical challenges and applications

…, C Swanton, U Hoffmann, LH Schwartz… - CA: a cancer journal …, 2019 - Wiley Online Library
Judgement, as one of the core tenets of medicine, relies upon the integration of multilayered
data with nuanced decision making. Cancer offers a unique context for medical decisions …

[HTML][HTML] Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging …

…, M Hutchings, SP Müeller, LH Schwartz… - Journal of clinical …, 2014 - ncbi.nlm.nih.gov
Purpose Recent advances in imaging, use of prognostic indices, and molecular profiling
techniques have the potential to improve disease characterization and outcomes in lymphoma. …

Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics

SE Wenzel, LB Schwartz, EL Langmack… - American journal of …, 1999 - atsjournals.org
The mechanisms associated with the development of severe, corticosteroid (CS)-dependent
asthma are poorly understood, but likely heterogenous. It was hypothesized that severe …

[PDF][PDF] Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in …

…, SN Reske, M Schwaiger, LH Schwartz… - Journal of clinical …, 2007 - researchgate.net
Purpose To develop guidelines for performing and interpreting positron emission
tomography (PET) imaging for treatment assessment in patients with lymphoma both in …